These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17013907)

  • 1. Problematic gambling on dopamine agonists: Not such a rarity.
    Grosset KA; Macphee G; Pal G; Stewart D; Watt A; Davie J; Grosset DG
    Mov Disord; 2006 Dec; 21(12):2206-8. PubMed ID: 17013907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists.
    Singh A; Kandimala G; Dewey RB; O'Suilleabhain P
    J Clin Neurosci; 2007 Dec; 14(12):1178-81. PubMed ID: 17720504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological gambling secondary to dopaminergic therapy in Parkinson's disease.
    Drapier D; Drapier S; Sauleau P; Derkinderen P; Damier P; Allain H; Vérin M; Millet B
    Psychiatry Res; 2006 Nov; 144(2-3):241-4. PubMed ID: 17011634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine agonist therapy for Parkinson disease and pathological gambling.
    Imamura A; Uitti RJ; Wszolek ZK
    Parkinsonism Relat Disord; 2006 Dec; 12(8):506-8. PubMed ID: 16723269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is dopamine agonist therapy associated with developing pathological gambling in Parkinson's disease patients?
    Zand R
    Eur Neurol; 2008; 59(3-4):183-6. PubMed ID: 18230877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease.
    Bandini F; Primavera A; Pizzorno M; Cocito L
    Parkinsonism Relat Disord; 2007 Aug; 13(6):369-71. PubMed ID: 17049455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of pathological gambling in patients with Parkinson's disease.
    Avanzi M; Baratti M; Cabrini S; Uber E; Brighetti G; Bonfà F
    Mov Disord; 2006 Dec; 21(12):2068-72. PubMed ID: 17044068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset.
    Giladi N; Weitzman N; Schreiber S; Shabtai H; Peretz C
    J Psychopharmacol; 2007 Jul; 21(5):501-6. PubMed ID: 17446202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine agonists and therapy compliance.
    Grosset D
    Neurol Sci; 2008 Dec; 29 Suppl 5():S375-6. PubMed ID: 19381766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents.
    Seedat S; Kesler S; Niehaus DJ; Stein DJ
    Depress Anxiety; 2000; 11(4):185-6. PubMed ID: 10945141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical hazards of the internet: gambling in Parkinson's disease.
    Larner AJ
    Mov Disord; 2006 Oct; 21(10):1789. PubMed ID: 16941457
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopamine agonist: pathological gambling and hypersexuality.
    Prescrire Int; 2008 Oct; 17(97):200-1. PubMed ID: 19536937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological gambling associated with dopamine agonist use in restless legs syndrome.
    Quickfall J; Suchowersky O
    Parkinsonism Relat Disord; 2007 Dec; 13(8):535-6. PubMed ID: 17270485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine agonists and pathological gambling.
    Grosset KA; Grosset DG; Macphee G; Pal G; Stewart D; Watt A; Davie J
    Parkinsonism Relat Disord; 2007 May; 13(4):259; author reply 260. PubMed ID: 17049451
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease.
    Avanzi M; Uber E; Bonfà F
    Neurol Sci; 2004 Jun; 25(2):98-101. PubMed ID: 15221629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological gambling caused by drugs used to treat Parkinson disease.
    Dodd ML; Klos KJ; Bower JH; Geda YE; Josephs KA; Ahlskog JE
    Arch Neurol; 2005 Sep; 62(9):1377-81. PubMed ID: 16009751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Parkinson's disease--where do we go from here?
    Suchowersky O
    Nat Clin Pract Neurol; 2006 Sep; 2(9):461. PubMed ID: 16932605
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies.
    Hassan A; Bower JH; Kumar N; Matsumoto JY; Fealey RD; Josephs KA; Ahlskog JE
    Parkinsonism Relat Disord; 2011 May; 17(4):260-4. PubMed ID: 21310646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective prevalence of pathologic gambling and medication association in Parkinson disease.
    Voon V; Hassan K; Zurowski M; Duff-Canning S; de Souza M; Fox S; Lang AE; Miyasaki J
    Neurology; 2006 Jun; 66(11):1750-2. PubMed ID: 16769956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease.
    Pezzella FR; Colosimo C; Vanacore N; Di Rezze S; Chianese M; Fabbrini G; Meco G
    Mov Disord; 2005 Jan; 20(1):77-81. PubMed ID: 15390130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.